Role of factor VIII-binding capacity of endogenous von Willebrand factor in the development of factor VIII inhibitors in patients with severe hemophilia A

被引：3

作者：

Repesse, Yohann ^{[1
,2
,3
]}

Costa, Catherine ^{[4
]}

Palla, Roberta ^{[5
]}

Moshai, Elika Farrokhi ^{[6
]}

Borel-Derlon, Annie ^{[1
,2
,3
]}

D'Oiron, Roseline ^{[7
]}

Rothschild, Chantal ^{[8
]}

El-Beshlawy, Amal ^{[9
]}

Elalfy, Mohsen ^{[10
]}

Ramanan, Vijay ^{[11
]}

Eshghi, Peyman ^{[12
]}

Oldenburg, Johannes ^{[13
]}

Pavlova, Anna ^{[13
]}

Rosendaal, Frits R. ^{[14
]}

Peyvandi, Flora ^{[5
]}

Kaveri, Srinivas V. ^{[6
]}

Lacroix-Desmazes, Sebastien ^{[6
]}

机构：

[1] CHU Caen, Hematol Lab, Caen, France

[2] INSERM, U1237, GIP Cyceron, Caen, France

[3] Normandie Univ, UNI CAEN, UFR Sante, Caen, France

[4] Grp Hosp Cochin Broca, AP HP, Hotel Dieu, Serv Genet & Biol Mol, Site Cochin, Paris, France

[5] Univ Milan, Dept Pathophysiol & Transplantat, Milan, Italy

[6] Univ Paris Diderot, Sorbonne Univ, USPC, Ctr Rech Cordeliers,INSERM, Paris, France

[7] AP HP, Ctr Traitement Hemophilie, Le Kremlin Bicetre, France

[8] Hop Necker Enfants Malad, AP HP, Ctr Traitement Hemophilie, Paris, France

[9] Cairo Univ, Pediat Hosp, Pediat Hematol Dept, Cairo, Egypt

[10] Cairo Univ, Ain Shams Ctr, Dept Pediat, Fac Med, Cairo, Egypt

[11] Jehangir Hosp Premises, Jehangir Clin Dev Ctr, Dept Hematol, Pune, Maharashtra, India

[12] Shahid Beheshti Univ Med Sci, Pediat Congenital Hematol Disorders Res Ctr, Tehran, Iran

[13] Univ Clin Bonn, Inst Expt Hematol & Transfus Med, Bonn, Germany

[14] Leiden Univ, Med Ctr, Dept Clin Epidemiol, Leiden, Netherlands

来源：

HAEMATOLOGICA | 2019年 / 104卷 / 08期

关键词：

COAGULATION FACTOR-VIII; VONWILLEBRAND-FACTOR; FACTOR GENE; POLYMORPHISMS; MUTATIONS; IMMUNOGENICITY; ANTIBODIES; FVIII;

D O I：

10.3324/haematol.2018.212001

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：E369 / E372

页数：4

共 50 条

[21] Co-expression of von Willebrand factor with factor VIII in epidermis augments circulating factor VIII in hemophilia a mice
Goldbeck, AL
Kobayashi, S
Lu, H
Sankar, R
Fakharzadeh, SS
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2002, 119 (01) : 264 - 264
[22] Factor VIII inhibitors in patients with non-severe hemophilia
Kempton, C. L.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 : 78 - 79
[23] Kinetics of factor VIII binding to deletion variants of von Willebrand factor
Vlot, AJ
Koppelman, SJ
Meijers, JCM
Willems, GM
vandenBerg, MH
Bouma, BN
Sixma, JJ
THROMBOSIS AND HAEMOSTASIS, 1997, : P2562 - P2562
[24] Inhibitors of Factor VIII in Hemophilia
Lacroix-Desmazes, Sebastien
Dimitrov, Jordan D.
Repesse, Yohann
NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (03): : 308 - 308
[25] Cleavage of von Willebrand Factor by Granzyme M Destroys Its Factor VIII Binding Capacity
Hollestelle, Martine J.
Lai, Ka Wai
van Deuren, Marcel
Lenting, Peter J.
de Groot, Philip G.
Sprong, Tom
Bovenschen, Niels
PLOS ONE, 2011, 6 (09):
[26] Normal Cleavage of Von Willebrand Factor by ADAMTS13 In the Absence of Factor VIII In Patients with Severe Hemophilia A.
Chen, Junmei
Chung, Dominic W.
Le, Jennie
Konkle, Barbara A.
Lopez, Jose A.
BLOOD, 2010, 116 (21) : 875 - 875
[27] Influence of the type of factor VIII concentrate on the incidence of factor VIII inhibitors in previously untreated patients with severe hemophilia A
Goudemand, J
Rothschild, C
Demiguel, V
Vinciguerrat, C
Lambert, T
Chambost, H
Borel-Derlon, A
Claeyssens, S
Laurian, Y
Calvez, T
BLOOD, 2006, 107 (01) : 46 - 51
[28] DOES THE CONCENTRATION OF VON WILLEBRAND FACTOR IN FACTOR VIII DEFICIENT PLASMA INFLUENCE THE FACTOR VIII LEVEL IN PLASMA SAMPLES FROM HEMOPHILIA A PATIENTS?
Verdickt, Laurence
Latinne, Dominique
Eeckhoudt, Stephane
INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2013, 35 : 78 - 78
[29] Heterogeneity in the half-life of factor VIII concentrate in patients with hemophilia A is due to variability in the clearance of endogenous von Willebrand factor
Elsheikh, Einas
Lavin, Michelle
Heck, Lilian Antunes
Larkin, Niamh
Mullaney, Brendan
Doherty, Dearbhla
Kennedy, Megan
Keenan, Catriona
Guest, Thomas
O'Mahony, Brian
Fazavana, Judicael
Fallon, Padraic G.
Preston, Roger J. S.
Gormley, John
Ryan, Kevin
O'Connell, Niamh M.
Singleton, Evelyn
Byrne, Mary
McGowan, Mark
Roche, Sheila
Doyle, Mairead
Crowley, Maeve P.
O'Shea, Susan I.
Reipert, Birgit M.
Johnson, Jill M.
Pipe, Steven W.
Di Paola, Jorge
Turecek, Peter L.
O'Donnell, James S.
iPATH study Grp
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2023, 21 (05) : 1123 - 1134
[30] Immune tolerance therapy utilizing factor VIII/von Willebrand factor concentrate in haemophilia A patients with high titre factor VIII inhibitors
Kurth, M. A. H.
Dimichele, D.
Sexauer, C.
Sanders, J. M.
Torres, M.
Zappa, S. C.
Ragni, M.
Leonard, N.
HAEMOPHILIA, 2008, 14 (01) : 50 - 55

← 1 2 3 4 5 →